The evolutionary history of metastatic pancreatic neuroendocrine tumors reveals a therapy driven route to high-grade transformation

被引:0
|
作者
Backman, S. [1 ]
Botling, J. [2 ,3 ]
Nord, H. [4 ]
Ghosal, S. [5 ]
Stalberg, P. [1 ]
Juhlin, C. C. [6 ]
Hellman, P. [1 ]
Skogseid, B. [7 ]
Pacak, K. [5 ]
Mollazadegan, K. [7 ]
Akerstrom, T. [1 ]
Crona, J. [7 ]
机构
[1] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden
[2] Uppsala Univ, Uppsala, Sweden
[3] Univ Gothenburg, Gothenburg, Sweden
[4] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden
[5] NIH, Sect Med Neuroendocrinol, Bethesda, MD USA
[6] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden
[7] Uppsala Univ, Dept Med Sci, Uppsala, Sweden
关键词
pancreatic neuroendocrine tumor; tumor evolution; alkylating chemotherapy; treatment resistance;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A03
引用
收藏
页码:20 / 20
页数:1
相关论文
共 50 条
  • [31] Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances
    Tetsuhide Ito
    Hisato Igarashi
    Robert T. Jensen
    Journal of Gastroenterology, 2012, 47 : 941 - 960
  • [32] Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances
    Ito, Tetsuhide
    Igarashi, Hisato
    Jensen, Robert T.
    JOURNAL OF GASTROENTEROLOGY, 2012, 47 (09) : 941 - 960
  • [33] Optimal Combination of Neuroendocrine Markers for the Detection of High-Grade Neuroendocrine Tumors of the Sinonasal Tract and Lung
    Weissferdt, Annikka
    Sepesi, Boris
    Ning, Jing
    Hermsen, Mario
    Ferrarotto, Renata
    Glisson, Bonnie
    Hanna, Ehab
    Bell, Diana
    CURRENT ONCOLOGY REPORTS, 2023, 25 (01) : 1 - 10
  • [34] Optimal Combination of Neuroendocrine Markers for the Detection of High-Grade Neuroendocrine Tumors of the Sinonasal Tract and Lung
    Annikka Weissferdt
    Boris Sepesi
    Jing Ning
    Mario Hermsen
    Renata Ferrarotto
    Bonnie Glisson
    Ehab Hanna
    Diana Bell
    Current Oncology Reports, 2023, 25 : 1 - 10
  • [35] The Problem of High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms Well-Differentiated Neuroendocrine Tumors, Neuroendocrine Carcinomas, and Beyond
    Sorbye, Halfdan
    Baudin, Eric
    Perren, Aurel
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (03) : 683 - +
  • [36] Combined deletion of MEN1, ATRX and PTEN triggers development of high-grade pancreatic neuroendocrine tumors in mice
    Fuentes, Mary Esmeralda
    Lu, Xiaoyin
    Flores, Natasha M.
    Hausmann, Simone
    Mazur, Pawel K.
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [37] Advances in understanding and management of high-grade pancreatic neuroendocrine neoplasm: a comprehensive review
    Regalla, Dileep Kumar Reddy
    Deep, Ojasvi
    Paluri, Ravi Kumar
    CHINESE CLINICAL ONCOLOGY, 2023, 12 (06)
  • [38] Pathology and Surgical Treatment of High-Grade Pancreatic Neuroendocrine Carcinoma: an Evolving Landscape
    Haugvik, Sven-Petter
    Kaemmerer, Daniel
    Gaujoux, Sebastien
    Labori, Knut Jorgen
    Verbeke, Caroline Sophie
    Gladhaug, Ivar Prydz
    CURRENT ONCOLOGY REPORTS, 2016, 18 (05)
  • [39] Pathology and Surgical Treatment of High-Grade Pancreatic Neuroendocrine Carcinoma: an Evolving Landscape
    Sven-Petter Haugvik
    Daniel Kaemmerer
    Sebastien Gaujoux
    Knut Jørgen Labori
    Caroline Sophie Verbeke
    Ivar Prydz Gladhaug
    Current Oncology Reports, 2016, 18
  • [40] A real-life treatment cohort of pancreatic neuroendocrine tumors: High-grade increase in metastases confers poor survival
    Zhang, Wu-Hu
    Gao, He-Li
    Liu, Wen-Sheng
    Qin, Yi
    Ye, Zeng
    Lou, Xin
    Wang, Fei
    Zhang, Yue
    Chen, Xue-Min
    Chen, Jie
    Yu, Xian-Jun
    Zhuo, Qi-Feng
    Xu, Xiao-Wu
    Ji, Shun-Rong
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13